MEF2C and chronic myelogenous leukemia, BCR-ABL1 positive: MEF-2C is one of the targets downregulated by miR-223, but the expression of MEF-2C is negatively correlated with miR-223 in CML patient samples, suggesting its role in CML pathogenesis [235].